MEDICA16
MEDICA16 is a dual GPR40 selective agonist and GPR120 partial agonist, as well as an ATP-citrate lyase inhibitor. It has been shown in research to lower intramuscular triglycerides and enhance insulin sensitivity in models like the gastrocnemius muscle, supporting metabolic disease studies.
Product Specifications
CAS Number
87272-20-6
Product Name Alternative
Antidiabetogenic, antidiabetic, ATP citrate lyase, ATPCitrateLyase, ATP Citrate Lyase, ACLY, GPR120, Free Fatty Acid Receptor, GPR40, FFAR, endogenous, MEDICA 16, MEDICA16, MEDICA-16, Inhibitor, insulin, muscle, inhibit, ligands, skeletal
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.13% (May vary between batches)
Solubility
DMSO:3.43 mg/mL (10.01 mM)
Smiles
CC (C) (CCCCCCCCCCC (C) (C) CC (O) =O) CC (O) =O
Molecular Formula
C20H38O4
Molecular Weight
342.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-7599R-PE-Cy7 100 µL
MST3/STK3 Polyclonal Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details 
37844066 1.0 µg DNA
Prss32 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
MBS6364926-01 0.1 mL
ZCCHC5, NT (ZCCHC5, Zinc finger CCHC domain-containing protein 5) (MaxLight 550)
Sign In for Pricing
View Details MBS6364926-02 5x 0.1 mL
ZCCHC5, NT (ZCCHC5, Zinc finger CCHC domain-containing protein 5) (MaxLight 550)
Sign In for Pricing
View Details